Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Ram

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Brain Research|February 17, 1987
S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic systemA Campbell, R J Baldessarini, N S Kula, et al.
Psychopharmacology|January 1, 1983
Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsyG M Anlezark, D H Blackwood, B S Meldrum, et al.
Journal of Medicinal Chemistry|August 1, 1982
Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphineJ L Neumeyer, G W Arana, V J Ram, et al.
Life Sciences|June 25, 1984
Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian speciesN S Kula, R J Baldessarini, A Campbell, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 21, 2004
A highly functionalized ferrocenylpyrazolo[2,3-a]pyridineS Sarkhel, P Srivastava, V J Ram, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brainY G Gao, V J Ram, A Campbell, et al.
European Journal of Pharmacology|January 8, 1982
An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphineR J Baldessarini, J L Neumeyer, A Campbell, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Brain Research|February 17, 1987
S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic systemA Campbell, R J Baldessarini, N S Kula, et al.
Psychopharmacology|January 1, 1983
Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsyG M Anlezark, D H Blackwood, B S Meldrum, et al.
Journal of Medicinal Chemistry|August 1, 1982
Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphineJ L Neumeyer, G W Arana, V J Ram, et al.
Life Sciences|June 25, 1984
Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian speciesN S Kula, R J Baldessarini, A Campbell, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 21, 2004
A highly functionalized ferrocenylpyrazolo[2,3-a]pyridineS Sarkhel, P Srivastava, V J Ram, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brainY G Gao, V J Ram, A Campbell, et al.
European Journal of Pharmacology|January 8, 1982
An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphineR J Baldessarini, J L Neumeyer, A Campbell, et al.
Pageof 3